[HTML][HTML] Adipokines in rheumatoid arthritis

ECS Fatel, FT Rosa, I Dichi - Advances in Rheumatology, 2019 - SciELO Brasil
Rheumatoid arthritis affects millions of people worldwide and is considered a chronic
multisystem disease whose causes are unknown. In general, the main objective of …

Adiponectin deregulation in systemic autoimmune rheumatic diseases

N Brezovec, K Perdan-Pirkmajer, S Čučnik… - International journal of …, 2021 - mdpi.com
Deregulation of adiponectin is found in systemic autoimmune rheumatic diseases (SARDs).
Its expression is downregulated by various inflammatory mediators, but paradoxically …

Visfatin as a therapeutic target for rheumatoid arthritis

E Franco-Trepat, A Alonso-Pérez… - Expert Opinion on …, 2019 - Taylor & Francis
Introduction: The rising prevalence of musculoskeletal pathologies in developed countries
has caused a dramatic impact on social welfare. Amidst these musculoskeletal pathologies …

[PDF][PDF] Adipokines: mediators of immunity and inflammation

R Kharbanda, T Bansal - Int J Res Med Sci, 2020 - academia.edu
White adipose tissue has emerged as a highly dynamic organ that releases a plethora of
immune and inflammatory mediators that are involved in obesity, metabolic syndrome and …

Visfatin in Association with Severity and Activity of Primary Osteoarthritis and Rheumatoid Arthritis

D Allam, AEW Shams El Din… - Benha medical …, 2021 - bmfj.journals.ekb.eg
Background: Visfatin is a one of the recently discovered adipokine that has important pro-
inflammatory and catabolic roles in rheumatoid arthritis (RA). Pro-inflammatory cytokines …

Avaliação das adipocitocinas pré e pós tratamento com tocilizumabe em pacientes com artrite reumatoide

ABSB Freitas - 2015 - bdtd.uerj.br
Universidade do Estado do Rio de Janeiro Centro Biomédico Faculdade de Ciências Médicas
Ana Beatriz Santos Bacchiega de Freit Page 1 Universidade do Estado do Rio de Janeiro …